Clinical trial
Golimumab for Adherence in Rheumatoid Arthritis
NCT03729349 is registered in ClinicalTrials.gov with Janssen Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Golimumab for Adherence in Rheumatoid Arthritis
- Lead sponsor
- Janssen Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 15, 2019
- Completion date
- June 19, 2023
- Enrollment
- 222 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.